Track topics on Twitter Track topics that are important to you
CINCINNATI and DURHAM, N.C., July 31, 2017 /PRNewswire/ -- Schulman IRB, the industry-leading central IRB in customer service and technology, is pleased to announce the formal launch of its Central Neurology Review (CNR) service.
Through its partnership with the National Biomedical Research Ethics Council (NBREC), a Nevada-based 501(c) non-profit, Schulman developed CNR to assist research institutions and biopharma and device companies in navigating the latest developments in neurology research and human subject protections.
"As neurology research continues to evolve at a rapid rate, we saw the need to create a specialized IRB model that conducts neurology-focused scientific and regulatory review for multi-site studies," said Eli Alford, Schulman's Chief Operating Officer. "Together with NBREC, we're excited to launch CNR and look forward to supporting the development of the latest techniques, methodologies and discoveries in neurology research."
CNR features a scientific review committee to complement Schulman's best-in-class IRB review. CNR is therapeutically focused and comprised of distinguished scientists and industry leaders who have experience conducting neurology research. By combining the robust expertise of a local IRB, the collaborative capabilities of a central IRB, and the leading minds in neurology research, CNR delivers independent, objective and authoritative review services.
About Schulman IRB
Schulman IRB has been a leader in the protection of human research participants in the U.S., Puerto Rico and Canada since 1983. Schulman offers thorough, timely IRB review services – including dedicated review capabilities for all phases of research across all therapeutic areas – to clinical trial sponsors, CROs, investigators and institutions. Schulman also provides global consulting services in clinical quality assurance (CQA) and human research protections (HRP), and it also offers a commercial institutional biosafety committee (IBC) service. Fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), Schulman has an unparalleled clean audit history with the Food and Drug Administration (FDA).
Established in 2012 as a Nevada-based 501(c)(3) not-for-profit organization, the National Biomedical Research Ethics Council (NBREC) is committed to the goals of assuring individual research volunteer safety through the expanded use of single ethics committees, expanding international awareness for research ethics and improving population public health efforts allied with disease surveillance and control.
For more information, please visit http://nbrec.org.
View original content with multimedia:http://www.prnewswire.com/news-releases/schulman-irb-launches-central-neurology-review-cnr-service-300496536.html
SOURCE Schulman IRBNEXT ARTICLE
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...
Bioethics is the study of controversial ethics brought about by advances in biology and medicine. Bioethicists are concerned with the ethical questions that arise in the relationships among life sciences, biotechnology, medicine, politics, law, and philo...